Tendon injuries represent a significant challenge to treat owing to their limited intrinsic reparative capacity. The use of mesenchymal stem cells (MSC) offers promising alternative therapeutic option to augments tendon repair. It is hypothesised that the activation of hypoxia inducible factor-1 alpha (HIF-1α), could facilitate the tendon repair process by promoting the proliferation and tenogenic differentiation of MSCs. To demonstrate this, a study was conducted incorporating the use of Roxadustat, a specific hypoxia mimetic mediator and cyclic uniaxial stretching at a frequency of 1 Hz and 8 % strain on adipose derived-mesenchymal stromal cells (ADMSCs).

Methods

Cellular morphology, proliferation rate, tenogenic protein and gene expression levels from 8 different treatment groups were compared. These groups include untreated ADMSCs (Control), Roxadustat pre-conditioned ADMSCs (ROX), ADMSCs subjected CAY10585 treatment only (CAY), Roxadustat pre-conditioned ADMSCs with CAY10585 inhibition (ROX+CAY), ADMSCs subjected to uniaxial stretching only (S), Roxadustat pre-conditioned ADMSCs with uniaxial stretching (ROX+S), ADMSCs subjected CAY10585 with uniaxial stretching (CAY+S) and primary tenocytes (Tenocytes).

Results

ROX+S group exhibited the highest expression of HIF-1α and demonstrated a significant up-regulation of collagen I and III expressions, increasing by 4.9 and 5.6-fold compared to ROX group, respectively. There is a significant increase of SCX, TNC, TNMD, COLI and COLIII expression in this combination treatment group; (SCX= 9.9, TNC= 12.6, TNMD= 7.0, COLI= 8.0 and COLIII= 10.0-fold). Conversely, the expression of the markers markedly reduced with HIF-1α inhibitor CAY10585. However, uniaxial stretching effectively counteracted the inhibitory effects of CAY10585 in the CAY+ S group, resulting in a 3.9-fold increase in SCX expression compared to CAY treatment alone.

Conclusion

HIF-1α accumulation promotes superior tenogenic differentiation of ADMSCs, suggesting that the combination of Roxadustat and cyclic uniaxial stretching may be a potential therapeutic mediator in tendon repair strategies.

Keywords

Cyclic uniaxial stretching; Hypoxia Pre-conditioning; Mechanotransduction; Mesenchymal stem cells (MSCs); Tenogenic differentiation.

1. H. Abdollahi et al. The role of hypoxia in stem cell differentiation and therapeutics. J. Surg. Res. (2011)
2. G. Chen et al. Mkx mediates tenogenic differentiation but incompletely inhibits the proliferation of hypoxic MSCs. Stem Cell Res. Ther. (2021)
3. J. Chen et al. Matrix metalloproteinases in normal pregnancy and preeclampsia. Prog. Mol. Biol. Transl. Sci. (2017)
4. H. Choudhry et al. Advances in hypoxia-inducible factor biology. Cell Metab. (2018)
5. J. Fu et al. Modulation of the mechanosensing of mesenchymal stem cells by laser-induced patterning for the acceleration of tissue reconstruction through the Wnt/β-catenin signaling pathway activation. Acta Biomater. (2020)
6. C.S. Lim et al. Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. J. Vasc. Surg. (2011)
7. N. Maffulli et al. Types and epidemiology of tendinopathy. Clin. Sports Med. (2003)
8. S. Vermeulen et al. Mechanotransduction is a context-dependent activator of TGF-β signaling in mesenchymal stem cells. Biomaterials (2020)
9. W. Widowati et al. Conditioned medium from normoxia (WJMSCs-norCM) and hypoxia-treated WJMSCs (WJMSCs-hypoCM) in inhibiting cancer cell proliferation. Biomark. Genom. Med. (2015)
10. A. Albanese et al. The role of hypoxia-inducible factor post-translational modifications in regulating its localisation, stability, and activity. Int. J. Mol. Sci.(2020)
11. C. Argentati et al. Insight into mechanobiology: how stem cells feel mechanical forces and orchestrate biological functions. Int. J. Mol. Sci. (2019)
12. M.R. Buckley et al. Distributions of types I, II and III collagens by region in the human supraspinatus tendon. Connect. Tissue Res. (2013)
13. J. Burk et al. Induction of tenogenic differentiation mediated by extracellular tendon matrix and short-term cyclic stretching. Stem Cells Int. (2016)
14. C.S. Chamberlain et al. Mesenchymal stem cell therapy on tendon/ligament healing. J. Cytokine Biol. (2017)
15. M.R. Citeroni et al. In vitro innovation of tendon tissue engineering strategies. Int. J. Mol. Sci. (2020)
16. L. Fan et al. The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration. BioMed. Res. Int. (2014)
17. W.K. Grier et al. Cyclic tensile strain enhances human mesenchymal stem cell Smad 2/3 activation and tenogenic differentiation in anisotropic collagen-glycosaminoglycan scaffolds. Eur. Cells Mater. (2017)
18. X. Guo et al. Adipose-derived mesenchymal stem cells with hypoxic preconditioning improve tenogenic differentiation. J. Orthop. Surg. Res. (2022)
19. E. Havis et al. TGFβ and FGF promote tendon progenitor fate and act downstream of muscle contraction to regulate tendon differentiation during chick limb development. Dev. (Camb., Engl.)(2016)
20. P. He et al. Comparison of tendon development versus tendon healing and regeneration. Front. Cell Dev. Biol. (2022)
21. A. Heirani-Tabasi et al. Comparison the effects of hypoxia-mimicking agents on migration-related signaling pathways in mesenchymal stem cells. Cell Tissue Bank. (2020)
22. Y. Huang et al. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer. J. Exp. Clin. Cancer Res. (2021)
23. P.A. Janmey et al. Stiffness Sensing by Cells Physiol. Rev. (2020)
24. Kalpakci, K.N., Brown, W.E., Hu, J.C., & Athanasiou, K.A. (2014). Cartilage tissue engineering using dermis isolated…